NPC GOLD is a non-invasive blood test that screens for nasopharyngeal cancer (NPC) by detecting Epstein-Barr virus (EBV) BamHI-W CpG-island DNA in the blood.
Detection rate for BamHI-W CpG DNA qPCR is 32.3% (41 vs 31) higher compared to single copy EBV [1], [2].
Available internationally outside the USA.
Specifications
89%
Sensitivity
100%
Specificity
50 IU/mL
LOD
NPC GOLD may be suitable for:
-
Individuals at risk
-
Asians aged 40 and above
-
Exposure to air pollutants
-
Salted fish consumption
-
Smoker
-
-
Individuals with a family member who has been diagnosed with nose cancer
-
Individuals experiencing nose bleeds, painless neck lumps, hearing loss, facial pain/numbness, and blurred/double vision.
Post test recommendations:
Downloads
References:
-
Vo, J. H. et al. Scientific Reports. 2016;6(1):1-9
-
Tan, M.H. & Vo, J. H. 2016. PCT/SG2016/050611